The lipid profile as a marker for predicting the severity of dengue fever
DOI:
https://doi.org/10.18203/2349-3933.ijam20211477Keywords:
Dengue fever, Severity, Total cholesterol, LDL-C, HDL-C, TriglyceridesAbstract
Background: Dengue fever is a mosquito-borne viral disease. WHO currently estimates 390 million dengue infections annually worldwide. In India between 2015 to 2020, out of 7,08,783 cases about 1,144 deaths have been reported according to National vector borne disease control programme data. This study aims at evaluating the changes in lipid profile among dengue patients with relation to severity and complications.
Methods: It is a cross sectional observational study conducted on 200 patients. The dengue patients were grouped according to WHO classification. The lipid profile was estimated and changes in its parameters were correlated with severity of dengue infection.
Results: The age distribution in our study was between 18 to 65 years with mean age of 28.5±9.2 years. As per WHO 2009 criteria out of 200 patients, 120 (60%) were dengue without warning signs, 68 (34%) were dengue with warning signs and 12 (6%) were severe dengue. There was decreased total cholesterol, LDL-C, HDL-C found in all forms of dengue and statistically significant (p<0.05) lowest levels noted in patients with severe disease according to ANOVA test. Correlation analysis showed a significant negative correlation between LDL-C (r=-0.716), HDL-C (r=-0.657) and total cholesterol(r=-0.621) with relation to severity of dengue (p<0.05).
Conclusions: Results of this study showed serum cholesterol levels are important correlates of dengue pathophysiology and severity and these may be used as a marker for predicting the severity of dengue fever.
Metrics
References
Factsheet: dengue and severe dengue. Available at: https://www.who.int/news-room/fact-sheets/detail/ dengue-and-severe-dengue. Accessed on 25 January 2020.
Uno N, Ross TM. Dengue virus and the host innate immune response. Emerg Microbes Infect. 2018; 7(1):167-11.
Farrar J, Yacoub S. Dengue In : Farrar J, Hotez JP, Junghanss T, Kang G, Lallo D, White N, eds. Manson's tropical diseases. 23rd ed. United States: Elsevier Saunders; 2014:162-70.
Document: dengue guidelines for diagnosis, treatment, prevention and control. Available at : https://www.who.int/tdr/publications/documents/dengue-diagnosis.pdf. Accessed on 25 January 2020.
Arunachalam N, Murty US, Kabilan L, Balasubramanian A, Thenmozhi V, Narahari D, et al. Studies on dengue in rural areas of Kurnool district, Andhra Pradesh, India. J Am Mosq Control Assoc. 2004;20:87-90.
Gupta N, Srivastava S, Jain A, Chaturvedi U. Dengue in India. Indian J Med Res. 2012;136(3): 373-90.
Factsheet : dengue/dhf situation in India. Available at: https://nvbdcp.gov.in/index4.php?lang=1&level= 0&linkid=431&lid=3715. Accessed on 25 January 2020.
Lee C-J, Lin HR, Liao CL, Lin YL. Cholesterol effectively blocks entry of flavivirus. J Virol. 2008; 82:6470-80.
Konkle BA. Disorders of platelets and vessel wall. In: Kasper DL, Fauci AS, Hauser SL, Jameson LJ, Longo DL, Loscalzo J, eds. Harrison’s principles of internal medicine. 20th ed. NewYork: McGraw-Hill Education; 2018:822-9.
Yacoub S, Mongkolsapaya J, Screaton G. Recent advances in understanding dengue. Research. 2016;5:78.
Padmaprakash K, Jha V, Bhushan S, Karantha S. Demographic and clinical profile of dengue fever in a tertiary care hospital of South India. J Assoc Physician India. 2020;68(3):68-73.
Rabbani M, Aslam M, Zaheer M, Ashraf M. Clinical and laboratory profile of dengue fever in a north indian tertiary hospital. J Assoc Physician India. 2018;66(4):55-9.
Eong OE. Changing pattern of dengue transmission in Singapore. Dengue Bull. 2001; 25:40-4.
Anker M, Arima Y. Male-female differences in the number of reported incident dengue fever cases in six Asian countries. Western Pacific Surveil Res. 2011; 2(2):e1-9.
Huy B, Hoa L, Thuy D, Van Kinh N, Ngan T, Duyet L, et al. Epidemiological and clinical features of dengue infection in adults in the 2017 outbreak in Vietnam. Bio Med Res Int. 2019;2019:1-6.
Suvarna J, Rane P. Serum lipid profile: a predictor of clinical outcome in dengue infection. Trop Med Int Health. 2009;14(5):576-85.
Van Gorp E, Suharti C, Mairuhu A, Dolmans W, van der Ven J, Demacker P, et al. Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever. Clin Infect Dis. 2002;34(8):1150-3.
Lima W, Souza N, Fernandes S, Cardoso V, Godói I. Serum lipid profile as a predictor of dengue severity: A systematic review and meta-analysis. Rev Med Virol. 2019;29(5):59-65.
Soto-Acosta R, Mosso C, Cervantes-Salazar M, Puerta-Guardo H, Medina F, Favari L, et al. The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in LDL particle uptake and HMG-CoA reductase activity. Virol. 2013;442(2):132-47.
Póvoa T, Alves A, Oliveira C, Nuovo G, Chagas V, Paes M. The Pathology of severe dengue in multiple organs of human fatal cases: histopathology, ultrastructure and virus replication. PLoS ONE. 2014;9(4):e83386.
Ly H, Francone OL, Fielding CJ, Shigenaga JK, Moser AH, Grunfeld C, et al. Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. J Lipid Res. 1995;36(6):1254-63.
Cherupanakkal C, Samadanam D, Muthuraman K, Ramesh S, Venkatesan A, Balakrishna PA, et al. Lipid peroxidation, DNA damage, and apoptosis in dengue fever. IUBMB Life. 2018;70(11):1133-43.
Heaton N, Perera R, Berger K, Khadka S, LaCount D, Kuhn R, et al. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proceed Nat Acad Sci. 2010;107(40):17345-50.
Durán A, Carrero R, Parra B, González A, Delgado L, Mosquera J, et al. Association of lipid profile alterations with severe forms of dengue in humans. Arch Virol. 2015;160(7):1687-92.
